| Stage | CAT | % of rev | CNH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $20.5B | 100.00% | $4.8B | 100.00% | CAT ×4.28 |
| Gross profit | $7.8B | 37.78% | $1.4B | 29.29% | CAT +8.5pp |
| Operating income | $4.3B | 20.91% | $544M | 11.33% | CAT +9.6pp |
| Pre-tax income | $4.6B | 22.19% | $172M | 3.58% | CAT +18.6pp |
| Net income | $3.6B | 17.49% | $141M | 2.94% | CAT +14.6pp |
| Stage | CAT | CNH | Gap · A − B |
|---|---|---|---|
| Revenue | $20.5B100.00% | $4.8B100.00% | CAT ×4.28 |
| Gross profit | 37.78%$7.8B | 29.29%$1.4B | CAT +8.5pp |
| Operating income | 20.91%$4.3B | 11.33%$544M | CAT +9.6pp |
| Pre-tax income | 22.19%$4.6B | 3.58%$172M | CAT +18.6pp |
| Net income | 17.49%$3.6B | 2.94%$141M | CAT +14.6pp |
No shared counterparties.